LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 87.14 | 771.67 | 8740 | 12592 | 0.6941 | 0.8267 | MN20160304_L01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 2.49 | 771.67 | 868 | 867 | 1.0003 | 1.0034 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 2.49 | 771.67 | 908 | 867 | 1.0464 | 1.6142 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 4.71 | 771.67 | 963 | 956 | 1.0069 | 1.0451 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 4.71 | 771.67 | 938 | 956 | 0.9808 | 0.8785 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 6.94 | 771.67 | 1029 | 1045 | 0.9846 | 0.9302 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 6.94 | 771.67 | 1067 | 1045 | 1.0209 | 1.0969 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 9.16 | 771.67 | 1123 | 1138 | 0.9864 | 0.9517 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 9.16 | 771.67 | 1230 | 1138 | 1.0804 | 1.2954 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 11.56 | 771.67 | 1215 | 1280 | 0.9488 | 0.8611 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 11.56 | 771.67 | 1370 | 1280 | 1.0698 | 1.1934 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 13.78 | 771.67 | 1359 | 1459 | 0.9310 | 0.8504 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 13.78 | 771.67 | 1538 | 1459 | 1.0536 | 1.1168 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 16.00 | 771.67 | 1507 | 1585 | 0.9505 | 0.9046 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 16.00 | 771.67 | 1644 | 1585 | 1.0369 | 1.0710 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 18.22 | 771.67 | 1526 | 1741 | 0.8763 | 0.7873 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 18.22 | 771.67 | 1693 | 1741 | 0.9722 | 0.9526 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 20.44 | 771.67 | 1541 | 1910 | 0.8064 | 0.6967 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 20.44 | 771.67 | 1610 | 1910 | 0.8426 | 0.7545 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 22.66 | 771.67 | 1650 | 2141 | 0.7705 | 0.6755 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 22.66 | 771.67 | 1699 | 2141 | 0.7934 | 0.7091 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.89 | 771.67 | 1710 | 2397 | 0.7132 | 0.6266 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.89 | 771.67 | 1911 | 2397 | 0.7970 | 0.7409 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 27.11 | 771.67 | 1825 | 2675 | 0.6822 | 0.6160 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 27.11 | 771.67 | 2061 | 2675 | 0.7704 | 0.7293 | MN20160304_L01 | M17 |